Affordable Access

Publisher Website

Pharmacokinetics of halofuginone in cattle

Authors
Journal
British Veterinary Journal
0007-1935
Publisher
Elsevier
Publication Date
Volume
145
Issue
6
Identifiers
DOI: 10.1016/0007-1935(89)90116-4
Disciplines
  • Pharmacology

Abstract

Abstract The pharmacokinetics of the antitheilerial drug halofuginone were evaluated in healthy calves following oral administration, at a dose of 1·2 mg/kg body weight, repeated after 48 h. The maximum plasma concentration after the first dose ranged from 3·8 to 7·7 ng/ml (6·5 ng/ml, mean) and occurred at between 12 and 32 h (22 h, mean). After the second dose, the maximum plasma concentration was 4·8–8·6 ng/ml (7·2 ng/ml, mean) occurring between 12 and 32 h (17 h, mean). The apparent terminal elimination half-life ranged from 24·2 to 28·9 h with a harmonic mean of 27·3 h. No significant difference was found in the apparent volume of distribution and the body clearance between the values calculated after the first dose and the two doses. The results show that the concentrations which persist in plasma from 8 to 120 h are above the in-vitro concentration of halofuginone required to reduce by 50% the proportion of lymphoblastoid cells containing Theileria parva schizonts (EC 50=3 ng/ml), but the maximum plasma concentrations are only about 46% of the in-vitro optimal effective concentration, EC 80 (15 ng/ml).

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Pharmacokinetics of halofuginone in cattle.

on The British veterinary journal 1989

Chemotherapy of Theileria parva lawrencei infectio...

on The Onderstepoort journal of v... March 1983

[Chemotherapy of cattle theileriosis with halofugi...

on Revue d'élevage et de médeci... 1980

Pharmacokinetics and tissue distribution of halofu...

on Cancer Chemotherapy and Pharma... November 2001
More articles like this..